Found: 12
Select item for more details and to access through your institution.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1680, doi. 10.1002/ajh.27378
- By:
- Publication type:
- Article
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1636, doi. 10.1002/ajh.27365
- By:
- Publication type:
- Article
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E140, doi. 10.1002/ajh.26117
- By:
- Publication type:
- Article
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 749, doi. 10.1016/j.clml.2023.06.003
- By:
- Publication type:
- Article
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. e947, doi. 10.1016/j.clml.2022.06.013
- By:
- Publication type:
- Article
Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 235, doi. 10.1634/theoncologist.2019-0441
- By:
- Publication type:
- Article
Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 1, p. 1, doi. 10.1007/s11899-020-00603-3
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 711, doi. 10.1111/bjh.19551
- By:
- Publication type:
- Article
Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 368, doi. 10.1111/bjh.19521
- By:
- Publication type:
- Article
Inherited Moderate Factor X Deficiency Presenting as Cardiac Tamponade.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/9657516
- By:
- Publication type:
- Article
Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy.
- Published in:
- Case Reports in Oncological Medicine, 2020, p. 1, doi. 10.1155/2020/9021843
- By:
- Publication type:
- Article